
- Volume 0 0
INDEPENDENT PHARMACIES OPT FOR GENERICS PLAN
Some employers are encouraging their workers to bypasstheir insurance plans and purchase drugs directly from theirlocal pharmacies, figuring they could save money by not usingtheir health insurance, and workers could save money becausethe price of the drugs is cheaper than their insurance copays.
To take advantage of this growing trend, several independentpharmacies across the country have become more businesssavvy with their drug pricing. One example is a programcalled "1 Price Prescription," which promotes the sales ofabout 200 generic drugs at the cost of $18 for a 3-month supply.The prices also offer volume savings: $34 for 6 months,$48 for 9 months, and $60 for about a year. Patients pay outof pocket, without insurance or copays.
The program was developed by Dan Benamoz, chief executiveofficer of Pharmacy Development Services in Lantana, Fla,a consultant organization that provides business solutions andcoaching services to independent pharmacies. Not all pharmaciesrun the program in the same fashion, however;Benamoz and his team present the concept and the model,and pharmacies then shape it to their specific needs. "We'redoing this with pharmacies all over the country," saidBenamoz.
Articles in this issue
about 19 years ago
compounding HOTLINEabout 19 years ago
The Good and the Bad of High Cholesterolabout 19 years ago
Compounding Dental Applicationsabout 19 years ago
An Overview and Update of the Controlled Substances Act of 1970about 19 years ago
ccpa SPEAKS OUT: AMP Definition "Defines" Pharmacists out of Medicaidabout 19 years ago
Are We Really Ready? Preparing for Disastersabout 19 years ago
When the Patient Won't Take the Medicineabout 19 years ago
Community Commitment Earns RESPy Awardabout 19 years ago
Kerr's Center Concentrates on Health and Educationabout 19 years ago
Mandatory Periodic Breaks for Pharmacists UpheldNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























